HIPO is expected to report earnings to fall 190.79% to -21 cents per share on August 06
Q2'26
Est.
$-0.22
Q4'25
Beat
by $0.46
Q3'25
Beat
by $4.18
Q2'25
Beat
by $0.65
Q1'25
Missed
by $1.33
The last earnings report on February 25 showed earnings per share of 23 cents, beating the estimate of -21 cents. With 32.01K shares outstanding, the current market capitalization sits at 661.31M.
A.I.dvisor indicates that over the last year, HIPO has been loosely correlated with LMND. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if HIPO jumps, then LMND could also see price increases.
HIPO in upward trend: price expected to rise as it breaks its lower Bollinger Band on April 30, 2026
HIPO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 42 cases where HIPO's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where HIPO advanced for three days, in of 251 cases, the price rose further within the following month. The odds of a continued upward trend are .
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on May 15, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on HIPO as a result. In of 97 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for HIPO turned negative on April 30, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at .
HIPO moved below its 50-day moving average on May 13, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for HIPO crossed bearishly below the 50-day moving average on May 19, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 12 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HIPO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
Fundamental Analysis (Ratings)
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.474) is normal, around the industry mean (1.855). P/E Ratio (5.773) is within average values for comparable stocks, (14.818). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (4.791). HIPO has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.026). P/S Ratio (1.395) is also within normal values, averaging (1.370).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. HIPO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HIPO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 62, placing this stock worse than average.
